Second malignancies in patients with Hodgkin’s Lymphoma: Half a century of experience

PURPOSE: Therapeutic improvements for Hodgkin’s Lymphoma (HL) has resulted in excellent survival outcomes. Thus, patients are increasing susceptible to developing secondary malignancy (SM) a feared iatrogenic complication. MATERIALS & METHODS: We evaluated the SM risk in a cohort of patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Shbib Dabaja, Bouthaina, Boyce-Fappiano, David, Dong, Wenli, Damron, Ethan, Fang, Penny, Gunther, Jill, Rodriguez, Maria A., Strati, Paolo, Steiner, Raphael, Nair, Ranjit, Lee, Hun, Abou Yehia, Zeinab, Shihadeh, Ferial, Pinnix, Chelsea, Ng, Andrea K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121058/
https://www.ncbi.nlm.nih.gov/pubmed/35601797
http://dx.doi.org/10.1016/j.ctro.2022.04.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121058/
https://www.ncbi.nlm.nih.gov/pubmed/35601797
http://dx.doi.org/10.1016/j.ctro.2022.04.011

Ejemplares similares